Polarean Imaging PLC
Company Profile
Business description
Polarean Imaging PLC designs and manufactures medical drug-device combination companies operating in the high-resolution medical imaging market. Its only operating segment being the development and commercialization of gas polariser devices and ancillary instruments. Geographically, it derives majority of the revenue from the United States of America and also has a presence in Canada and the United Kingdom. The company generates revenue from products and services such as Polarisers, Parts and Upgrades, Service and other revenue. Its product portfolio includes 9820 129Xe Hyperpolarizer, 9800 129Xe Hyperpolarizer, Polarean 3777 129Xe Hyperpolarizer Upgrade Module, Polarean 2881 Polarization Measurement Station, and others.
Contact
27-28 Eastcastle Street
LondonW1W 8DH
GBRSector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
19
Stocks News & Analysis
stocks
Vote in favour of merger for undervalued ASX share
stocks
Are investors missing the boat on this future ASX leader?
stocks
ASX shares plunge but remain undervalued
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,560.50 | 103.70 | 1.23% |
| CAC 40 | 7,474.59 | 50.92 | 0.69% |
| DAX 40 | 20,574.68 | 303.35 | 1.50% |
| Dow JONES (US) | 43,221.55 | 703.27 | 1.65% |
| FTSE 100 | 8,301.13 | 99.59 | 1.21% |
| HKSE | 19,561.94 | 275.87 | 1.43% |
| NASDAQ | 19,511.23 | 466.84 | 2.45% |
| Nikkei 225 | 38,551.96 | 107.38 | 0.28% |
| NZX 50 Index | 12,995.67 | 52.10 | 0.40% |
| S&P 500 | 5,949.91 | 107.00 | 1.83% |
| S&P/ASX 200 | 8,319.20 | 105.90 | 1.29% |
| SSE Composite Index | 3,253.11 | 25.99 | 0.81% |